Stefania La Grutta, MD
11
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
9.1%
1 terminated/withdrawn out of 11 trials
90.9%
+4.4% vs industry average
18%
2 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters
Role: lead
CHildhood ASthma and Environment Research Study - CHASER Study
Role: lead
Study and Development of Application Models of "Therapeutic Education to the Patient" (TEP) in Asthmatic Children
Role: lead
Assessment of Asthma Knowledge Perception in Parents of Asthmatic Children. Pilot Study by Means of Q-KAP ( Questionnaire on Knowledge, Attitudes and Practices )
Role: lead
Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis
Role: lead
"Studio NaVA" - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without Asthma
Role: lead
Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study
Role: lead
CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in Children
Role: lead
Study in Children With the Diagnosis of Congenital Diaphragmatic Hernia (CDH) and Oesophageal Atresia (EA)
Role: lead
One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish
Role: lead
Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
Role: lead
All 11 trials loaded